Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-128210
Filing Date
2016-06-16
Accepted
2016-06-16 17:02:11
Documents
1
Period of Report
2016-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3834
  Complete submission text file 0001209191-16-128210.txt   5248
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Dineen John M. (Reporting) CIK: 0001645270 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35409 | Film No.: 161718142